Doliprane paracetamol

Doliprane is one of the most recognized and widely used pharmaceutical brands in France, primarily known for its formulation of paracetamol (acetaminophen). It is used to treat pain and fever in adults and children. The brand has been a staple of French medicine cabinets for decades and is closely associated with high-quality healthcare standards.

Historically, Doliprane was developed and manufactured by the French pharmaceutical company Rhone-Poulenc Rorer before it became part of the Sanofi group through various mergers. Today, it remains a flagship product for Sanofi, specifically within its consumer healthcare division. Most production occurs at specialized facilities in France, notably in Lisieux and Compiègne, ensuring tight quality control.

In recent corporate developments, Sanofi has taken steps to spin off its consumer healthcare business, Opella, into a separate entity. This move is part of a broader strategy to allow Sanofi to focus on innovative biopharmaceuticals and vaccines while enabling the consumer healthcare division to operate with its own dedicated resources and market strategy. Despite these structural changes, the brand's heritage remains firmly French.